Chicago Equity Partners’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-152,795
| Closed | -$7.08M | – | 1022 |
|
|
2019
Q2 | $7.08M | Buy |
152,795
+34,650
| +29% | +$973K | 0.32% | 70 |
|
|
2019
Q1 | $2.88M | Buy |
+118,145
| New | +$2.46M | 0.11% | 248 |
|
|
2018
Q3 | – | Sell |
-103,465
| Closed | -$1.74M | – | 928 |
|
|
2018
Q2 | $1.74M | Buy |
103,465
+3,165
| +3% | +$50.3K | 0.05% | 415 |
|
|
2018
Q1 | $1.64M | Buy |
+100,300
| New | +$1.61M | 0.05% | 415 |
|
|
2017
Q4 | – | Sell |
-220,907
| Closed | -$2.72M | – | 872 |
|
|
2017
Q3 | $2.72M | Sell |
220,907
-62,760
| -22% | -$583K | 0.09% | 310 |
|
|
2017
Q2 | $2.37M | Sell |
283,667
-129,863
| -31% | -$1.06M | 0.06% | 340 |
|
|
2017
Q1 | $3.7M | Sell |
413,530
-119,470
| -22% | -$1.27M | 0.11% | 208 |
|
|
2016
Q4 | $4.68M | Buy |
533,000
+47,220
| +10% | +$347K | 0.12% | 175 |
|
|
2016
Q3 | $3.28M | Sell |
485,780
-69,110
| -12% | -$267K | 0.09% | 216 |
|
|
2016
Q2 | $1.98M | Buy |
554,890
+544,700
| +5,345% | +$1.78M | 0.06% | 272 |
|
|
2016
Q1 | $30K | Hold |
10,190
| – | – | ﹤0.01% | 576 |
|
|
2015
Q4 | $43K | Sell |
10,190
-190
| -2% | -$867 | ﹤0.01% | 579 |
|
|
2015
Q3 | $47K | Buy |
+10,380
| New | +$61.5K | ﹤0.01% | 556 |
|
|
2014
Q1 | – | Sell |
-12,575
| Closed | -$63K | – | 505 |
|
|
2013
Q4 | $63K | Sell |
12,575
-225
| -2% | -$1.23K | ﹤0.01% | 412 |
|
|
2013
Q3 | $79K | Buy |
+12,800
| New | +$76K | ﹤0.01% | 431 |
|
Other funds holding ARRY
Chicago Equity Partners's ARRY Position: Q3 2019 in Review
Chicago Equity Partners sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 152,795 shares — an estimated $7.08M sold.
Chicago Equity Partners first reported a position in ARRY in Q3 2013 and held it in 15 quarters. The position peaked at $7.08M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.
- Chicago Equity Partners reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
- Chicago Equity Partners sold 152,795 Array Biopharma Inc shares in Q3 2019, an estimated $7.08M.
- Chicago Equity Partners first reported a position in Array Biopharma Inc in Q3 2013 and held it in 15 quarters.
- Chicago Equity Partners's Array Biopharma Inc position peaked at $7.08M in Q2 2019.
- 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.
Based on Chicago Equity Partners's 13F filing for Q3 2019, filed 30 Oct 2019.